Skip to content
MarketScale
‹ Back to IndustriesHealthcare

July Job Report Reveals Records and Reservation

U.S. labor force participation reached a record high in the month of July. Unemployment remained at 3.7% according to the latest jobs report from Bureau of Labor Statistics, released Friday, Aug. 2. Wages also increased 3.2% overall, an increase from June. Approximately 164,000 Non-farm payroll additions were made in July, while private-sector payrolls modestly under-preformed…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

U.S. labor force participation reached a record high in the month of July. Unemployment remained at 3.7% according to the latest jobs report from Bureau of Labor Statistics, released Friday, Aug. 2. Wages also increased 3.2% overall, an increase from June.

Approximately 164,000 Non-farm payroll additions were made in July, while private-sector payrolls modestly under-preformed Dow Jones and Moody’s expectations, at 148,000 for the month.

The strong job numbers are, however, a departure from consistent payroll increases of 200,000-plus the country experienced in 2018 and the first quarter of 2019. So far this year, average monthly job additions stand at 165,000, according to the Wall Street Journal. Analysts continue to point towards a trend stagnation in job growth for the remainder of the fiscal year.

Looking Ahead by Looking Back

Professional and technical services added 30,800 jobs and the health care sector added 30,400 accounting for two of the biggest payroll growths in July. Financial activities payrolls rose by 18,000 while the mining industry reported a loss of 5,000 jobs.

Today’s jobs report also significantly revised earlier numbers from what was supposedly a strong month of growth in June. The June payroll gain of 224,000 was reduced to 193,000. May’s sluggish job numbers have also been reduced from the reported 72,000 jobs down to 62,000.

Photo courtesy of the United States Bureau of Labor Statistics.

The record increase in workforce participation comes amid news that retailers like Lowe’s, which just announced thousands of layoffs at its stores, are continuing to close and reduce costs. This year alone, more than 7,000 store closures have been announced by US retailers–a staggering number that some analysts predict could reach up to 12,000 by the end of the year.

Who’s Winning, Who’s Losing?

Small businesses, specifically those with less than 20 employees, reported negative payroll numbers for the third consecutive month. They continue to struggle with labor shortages and competition from online retailers that are contributing to this decline.

Manufacturing employment had another month of modest job growth, with the country adding 16,000 new jobs. The American manufacturing industry has seen one of the most difficult periods for job growth over the past two quarters. This report comes in the midst of ongoing trade disputes and softening of the global market. US manufacturing work hours hit its lowest mark since 2011.

In the wake of a new round of tariffs on China, set to go in effect September 1st, the trade deficit between the two countries decreased 0.3% to 55.2 billion. Markets will be vigilant of the impact this new round of tariffs will have on American consumers along with worries of a global economic slowdown as the Federal Reserve voted Wednesday to cut their interest rate a quarter of a percent.

For the latest news, head to our industries pages! You can also follow us on Twitter @MarketScale for up-to-the-minute updates! Join the conversation in on Market Leaders LinkedIn Groups!

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512